Cited by 516Cannabis and Cannabinoid ResearchMedicinal Plant Extracts EffectsForensic Toxicology and Drug Analysis

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Cannabidiol—recent advances

Mechoulam, Raphael, Peters, Maximilian, Murillo‐Rodriguez, Eric, Hanuš, Lumír O.·2007·Chemistry & Biodiversity

DOI 10.1002/cbdv.200790147

Open this paper in CoChat — free account

Abstract

The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non-psychoactive constituent of Cannabis, and to give a general overview. Special emphasis is laid on biochemical and pharmacological advances, and on novel mechanisms recently put forward, to shed light on some of the pharmacological effects that can possibly be rationalized through these mechanisms. The plethora of positive pharmacological effects observed with CBD make this compound a highly attractive therapeutic entity.

Integrity signals

Registry

Crossref · 10.1002/cbdv.200790147

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315
Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor Mechanism
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 763
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
Russo, E. B., & Guy, G. W. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 608
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
Ligresti, A., Moriello, A. S., Starowicz, K., Matias, I., Pisanti, S., PETROCELLIS, L. D., Laezza, C., Portella, G., Bifulco, M., & Marzo, V. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105247 · Cited by 569
Cannabidiol: An Overview of Some Pharmacological Aspects
Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 530
Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression
Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497

Flagged first, then by citations

Show all 65 references

Research works printed but not linked: 2

10.1016/S0024-3205(04)00291-7 · DOI
Tucker A. N., 1977, Res. Commun. Chem. Pathol. Pharmacol., 17, 703

Sorted by citations

Items 201–300 of 516

The nonpsychoactive cannabis constituent cannabidiol is a wake-inducing agent.
Murillo‐Rodríguez, E., Millán‐Aldaco, D., Palomero‐Rivero, M., Mechoulam, R., & Drucker-Colı́n, R. (2008) · Behavioral Neuroscience · doi:10.1037/a0013278 · Cited by 47
Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage
Tetorou, K., Sisa, C., Iqbal, A., Dhillon, K., & Hristova, M. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.709301 · Cited by 43
Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Bright, U., & Akirav, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105526 · Cited by 48
Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models
Puighermanal, E., Luna‐Sánchez, M., Gella, A., van der Walt, G., Urpi, A., Royo, M., Tena‐Morraja, P., Appiah, I., de Donato, M. H., Ménardy, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51884-8 · Cited by 41
Flax Fiber Hydrophobic Extract Inhibits Human Skin Cells Inflammation and Causes Remodeling of Extracellular Matrix and Wound Closure Activation
Styrczewska, M., Kostyn, A., Kulma, A., Majkowska-Skrobek, G., Augustyniak, D., Prescha, A., Czuj, T., & Szopa, J. (2015) · BioMed Research International · doi:10.1155/2015/862391 · Cited by 42
Potential Effects of Cannabidiol as a Wake-Promoting Agent
Murillo‐Rodríguez, E., Sarro-Ramírez, A., Sanchez, D., Mijangos-Moreno, S., Tejeda-Padrón, A., Poot-Aké, A., Guzmán, K., Pacheco-Pantoja, E. L., & Arias-Carrión, Ó. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131204235805 · Cited by 42
Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration
Silveira, J. W. S., Issy, A. C., Castania, V., Salmón, C. E. G., Nogueira‐Barbosa, M. H., Guimarães, F. S., Defino, H. L. A., & Bel, E. A. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113161 · Cited by 42
Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?
Klahn, P. (2020) · Antibiotics · doi:10.3390/antibiotics9060297 · Cited by 43
Cannabidiol-induced lymphopenia does not involve NKT and NK cells.
Ignatowska-Jankowska, B. M., Jankowski, M. M., Glac, W., & Swiergel, A. H. (2009) · PubMed · Cited by 40
Cannabinoids for epilepsy
Gloss, D. S., & Vickrey, B. G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009270.pub2 · Cited by 41
Dronabinol and chronic pain: importance of mechanistic considerations
de Vries, M., van Rijckevorsel, D. C., Wilder‐Smith, O. H. G., & van Goor, H. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.918102 · Cited by 40
Human Pharmacokinetics and Adverse Effects of Pulmonary and Intravenous THC-CBD Formulations
Meyer, P., Langos, M., & Brenneisen, R. (2018) · Medical Cannabis and Cannabinoids · doi:10.1159/000489034 · Cited by 40
A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single‐dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers
Hosseini, A., McLachlan, A. J., & Lickliter, J. D. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14617 · Cited by 44
On-the-Spot Detection and Speciation of Cannabinoids Using Organic Thin-Film Transistors
Comeau, Z. J., Boileau, N. T., Lee, T., Melville, O. A., Rice, N. A., Troung, Y., Harris, C. S., Lessard, B. H., & Shuhendler, A. J. (2019) · ACS Sensors · doi:10.1021/acssensors.9b01150 · Cited by 39
Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins
Schönhofen, P., de Medeiros, L. M., Bristot, I. J., Lopes, F. M., Bastiani, M. A. D., Kapczinski, F. P., Crippa, J. A. S., Castro, M. A. A., Parsons, R. B., & Klamt, F. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8843-1 · Cited by 39
Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice
Zarrindast, M., Hosseindoost, S., & Nasehi, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.11.039 · Cited by 37
Cannabis Sativa Revisited—Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis
Dinu, A. R., Rogobete, A. F., Bratu, T., Popovici, S. E., Bedreag, O. H., Păpurică, M., Bratu, T., & Săndesc, D. (2020) · Cells · doi:10.3390/cells9020307 · Cited by 38
Cannabidiol modulation of hippocampal glutamate in early psychosis
O’Neill, A., Annibale, L., Blest‐Hopley, G., Wilson, R. P., Giampietro, V., & Bhattacharyya, S. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211001107 · Cited by 37
Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: Drug-discovery strategies
Janero, D. R., Vadivel, S. K., & Makriyannis, A. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782778 · Cited by 37
Medicinal Chemistry Endeavors around the Phytocannabinoids
Stern, E., & Lambert, D. M. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790149 · Cited by 38
Cannabinoid-like anti-inflammatory compounds from flax fiber
Styrczewska, M., Kulma, A., Ratajczak‐Wielgomas, K., Amarowicz, R., & Szopa, J. (2012) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-012-0023-6 · Cited by 37
Cannabinoids Δ9-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-κB signaling
Majdi, F., Taheri, F., Salehi, P., Motaghinejad, M., & Safari, S. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109371 · Cited by 37
Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story
Carbone, E., Manduca, A., Cacchione, C., Vicari, S., & Trezza, V. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.009 · Cited by 38
Protein Carbonylation as a Biomarker of Oxidative Stress and a Therapeutic Target in Neonatal Brain Damage
Martínez-Orgado, J. A., Martínez-Vega, M., Silva, L., Romero, A., de Hoz-Rivera, M., Villa, M., & del Pozo, A. (2023) · Antioxidants · doi:10.3390/antiox12101839 · Cited by 37
Combining the potential of 3D printed buccal films and nanostructured lipid carriers for personalised cannabidiol delivery
Abdella, S., Kim, S., Afinjuomo, F., Song, Y., Upton, R. N., & Garg, S. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01446-0 · Cited by 35
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
Juknat, A., Rimmerman, N., Levy, R., Vogel, Z., & Kozela, E. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.002 · Cited by 35
Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review
Madeo, G., Kapoor, A., Giorgetti, R., Busardò, F. P., & Carlier, J. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230322143401 · Cited by 43
Effect of cannabidiol on human gingival fibroblast extracellular matrix metabolism: MMP production and activity, and production of fibronectin and transforming growth factor β
Rawal, S. Y., Dabbous, M. K., & Tipton, D. A. (2011) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01435.x · Cited by 38
Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract
Stanzani, A., Galiazzo, G., Giancola, F., Tagliavia, C., Silva, M. D., Pietra, M., Fracassi, F., & Chiocchetti, R. (2020) · Histochemistry and Cell Biology · doi:10.1007/s00418-020-01854-0 · Cited by 38
Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury
Martínez-Orgado, J. A., Villa, M. P., & del Pozo, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.584533 · Cited by 34
The neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects
Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2828 · Cited by 34
Current trends on cannabidiol delivery systems: where are we and where are we going?
Ramalho, Í. M. D. M., Pereira, D. T., Galvão, G. B. L., Freire, D. T., Amaral-Machado, L., Alencar, É. D. N., & do Egito, E. S. T. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1952978 · Cited by 33
Inhibition of sodium conductance by cannabigerol contributes to a reduction of dorsal root ganglion neuron excitability
Ghovanloo, M., Estación, M., Higerd‐Rusli, G. P., Zhao, P., Dib‐Hajj, S. D., & Waxman, S. G. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15833 · Cited by 33
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy
Babayeva, M., Assefa, H., Basu, P., Chumki, S. R., & Loewy, Z. G. (2016) · Parkinson s Disease · doi:10.1155/2016/1279042 · Cited by 38
Cannabis use, harms and the management of cannabis use disorder
Copeland, J., Clement, N., & Swift, W. (2014) · Neuropsychiatry · doi:10.2217/npy.13.90 · Cited by 33
A little “dab” will do ya’ in: a case report of neuro-and cardiotoxicity following use of cannabis concentrates
Rickner, S. S., Cao, D. J., Kleinschmidt, K., & Fleming, S. W. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1334914 · Cited by 31
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol
Citti, C., Palazzoli, F., Licata, M., Vilella, A., Leo, G., Zoli, M., Vandelli, M. A., Forni, F., Pacchetti, B., & Cannazza, G. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.08.021 · Cited by 31
Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice
Nasehi, M., Yavari, S. A., & Zarrindast, M. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2987-y · Cited by 31
Natural Negative Allosteric Modulators of 5-HT3 Receptors
Kury, L. T. A., Mahgoub, M., Howarth, F. C., & Öz, M. (2018) · Molecules · doi:10.3390/molecules23123186 · Cited by 31
Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Campillo, N. E., & Paez, J. A. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788167628 · Cited by 31
Neuroprotection Following Concussion: The Potential Role for Cannabidiol
Singh, J., & Neary, J. P. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.23 · Cited by 30
Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats
Morais, H., Chaves, Y. C., Waltrick, A. P. F., Jesus, C. H. A., Genaro, K., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.006 · Cited by 32
The Conversion and Transfer of Cannabinoids from Cannabis to Smoke Stream in Cigarettes
Elzinga, S. (2015) · Natural Products Chemistry & Research · doi:10.4172/2329-6836.1000163 · Cited by 29
The future of type 1 cannabinoid receptor allosteric ligands
Alaverdashvili, M., & Laprairie, R. B. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1428341 · Cited by 29
Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
Bielawiec, P., Harasim‐Symbor, E., Konstantynowicz-Nowicka, K., Sztolsztener, K., & Chabowski, A. (2020) · Biomolecules · doi:10.3390/biom10091241 · Cited by 30
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
Greenwald, M. K., Moses, T. E. H., & Roehrs, T. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.006 · Cited by 29
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
Podda, G., & Constantinescu, C. S. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.721765 · Cited by 29
Medical uses of marijuana (Cannabis sativa): fact or fallacy?
Wj, M. (2015) · British Journal of Biomedical Science · doi:10.1080/09674845.2015.11666802 · Cited by 8
Cannabidiol restores differentiation capacity of LPS exposed adipose tissue mesenchymal stromal cells
Ruhl, T., Kim, B., & Beier, J. P. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.07.030 · Cited by 29
Cannabinoids for epilepsy
Gloss, D. S., & Vickrey, B. G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009270 · Cited by 29
Learning and memory is modulated by cannabidiol when administered during trace fear-conditioning
Uhernik, A. L., Montoya, Z. T., Balkissoon, C. D., & Smith, J. P. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.02.009 · Cited by 28
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
Nagarkatti, P. S., Miranda, K., & Nagarkatti, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.589438 · Cited by 29
Enhanced bioavailability and biosafety of cannabidiol nanomicelles for effective anti-inflammatory therapy
Rao, Y. M., Li, R., Liu, S., Meng, L., Wu, Q., Yuan, Q., Liang, H., & Qin, M. (2021) · Particuology · doi:10.1016/j.partic.2021.11.010 · Cited by 28
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity
Liu, D.-Z., Hu, C.-M., Huang, C.-H., Wey, S., & Jan, T. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.155 · Cited by 28
Differential effects of CB1 receptor agonism in behavioural tests of unconditioned and conditioned fear in adult male rats
Simone, J. J., Green, M. R., Hodges, T. E., & McCormick, C. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.012 · Cited by 30
The endocannabinoid system in migraine: from bench to pharmacy and back
Tassorelli, C., Greco, R., & Silberstein, S. D. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000688 · Cited by 32
An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors
Muller, C., & Reggio, P. H. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.615811 · Cited by 27
Effects of Cannabidiol on Locomotor Activity
Calapai, F., Cardia, L., Calapai, G., Mauro, D. D., Trimarchi, F., Ammendolia, I., & Mannucci, C. (2022) · Life · doi:10.3390/life12050652 · Cited by 27
Cannabidiol‐induced apoptosis in murine microglial cells through lipid raft
Wu, H., Goble, K., Mecha, M., Wang, C., Huang, C., Guaza, C., & Jan, T. (2012) · Glia · doi:10.1002/glia.22345 · Cited by 27
Localisation of cannabinoid and cannabinoid‐related receptors in the equine dorsal root ganglia
Chiocchetti, R., Rinnovati, R., Tagliavia, C., Stanzani, A., Galiazzo, G., Giancola, F., Silva, M. D., Capodanno, Y., & Spadari, A. (2020) · Equine Veterinary Journal · doi:10.1111/evj.13305 · Cited by 27
Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor
Gomes, F. V., Alves, F. H. F., Guimarães, F. S., Correa, F. M. A., Resstel, L. B. M., & Crestani, C. C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.007 · Cited by 27
Should Oncologists Recommend Cannabis?
Abrams, D. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0659-9 · Cited by 22
Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
Gómez, C. T., Lairion, F., Repetto, M. G., Ettcheto, M., Merelli, A., Lazarowski, A., & Auzmendi, J. (2021) · Pharmaceuticals · doi:10.3390/ph14030220 · Cited by 26
Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis
Chiocchetti, R., Salamanca, G., Silva, M. D., Gobbo, F., Aspidi, F., Cunha, R. Z., Galiazzo, G., Tagliavia, C., Sarli, G., & Morini, M. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.987132 · Cited by 29
A Novel Tetrahydrocannabinol Electrochemical Nano Immunosensor Based on Horseradish Peroxidase and Double-Layer Gold Nanoparticles
Lu, D., Lu, F., & Pang, G. (2016) · Molecules · doi:10.3390/molecules21101377 · Cited by 26
Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats
Santiago, A. N., Mori, M., Guimarães, F. S., Milani, H., & de Oliveira, R. M. W. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9972-5 · Cited by 26
Lack of positive allosteric modulation of mutated α1S267I glycine receptors by cannabinoids
Foadi, N., Leuwer, M., Demir, R., Dengler, R., Buchholz, V., de la Roche, J., Karst, M., Haeseler, G., & Ahrens, J. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0506-9 · Cited by 26
HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid
Haj, C. G., Sumariwalla, P. F., Hanuš, L., Kogan, N. M., Yektin, Z., Mechoulam, R., Feldmann, M., & Gallily, R. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226100 · Cited by 26
Cannabidiol reduces lung injury induced by hypoxic–ischemic brain damage in newborn piglets
Arruza, L., Pazos, M. R., Mohammed, N., Escribano, N., Lafuente, H., Santos, M., Alvarez, F. J., Hind, W. H., & Martínez-Orgado, J. A. (2017) · Pediatric Research · doi:10.1038/pr.2017.104 · Cited by 25
Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders
Sagredo, O., Palazuelos, J., Rodriguez, A. G., Satta, V., Galve‐Roperh, I., & Martínez-Orgado, J. A. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.014 · Cited by 27
Eight Weeks of Daily Cannabidiol Supplementation Improves Sleep Quality and Immune Cell Cytotoxicity
Kisiolek, J. N., Flores, V. A., Ramani, A. H., Butler, B., Haughian, J. M., & Stewart, L. K. (2023) · Nutrients · doi:10.3390/nu15194173 · Cited by 25
Atropisomerism about Aryl–Csp3 Bonds: The Electronic and Steric Influence of ortho-Substituents on Conformational Exchange in Cannabidiol and Linderatin Derivatives
Berber, H., Lameiras, P., Denhez, C., Antheaume, C., & Clayden, J. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo5006069 · Cited by 25
Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats
Murillo‐Rodríguez, E., Arankowsky‐Sandoval, G., Rocha, N., Peniche-Amante, R., Veras, A. B., Machado, S. E. D. C., & Budde, H. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2565-0 · Cited by 26
“Noids” in a nutshell: everything you (don’t) want to know about synthetic cannabimimetics
Papanti, D., Orsolini, L., Francesconi, G., & Schifano, F. (2014) · Advances in Dual Diagnosis · doi:10.1108/add-02-2014-0006 · Cited by 24
Synthetic biology, combinatorial biosynthesis, and chemo‑enzymatic synthesis of isoprenoids
Malico, A. A., Calzini, M. A., Gayen, A. K., & Williams, G. J. (2020) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-020-02306-3 · Cited by 26
Biosynthesis of Nature-Inspired Unnatural Cannabinoids
Lim, K. J. H., Lim, Y. P., Hartono, Y. D., Go, M. K., Fan, H., & Yew, W. S. (2021) · Molecules · doi:10.3390/molecules26102914 · Cited by 26
Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review
Fearby, N. L., Penman, S. L., & Thanos, P. K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063174 · Cited by 27
Recent advances in electrochemical sensor technologies for THC detection—a narrative review
Amini, K., Sepehrifard, A., Valinasabpouri, A., Safruk, J., Angelone, D., & Lourenco, T. D. C. (2022) · Journal of Cannabis Research · doi:10.1186/s42238-022-00122-3 · Cited by 25
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig
Dudášová, A., Keir, S. D., Parsons, M. E., Molleman, A., & Page, C. P. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.02.002 · Cited by 24
Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective
Karst, M., & Wippermann, S. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802691951 · Cited by 24
Molecular Mechanisms of Cannabis Signaling in the Brain
Ronan, P. J., Wongngamnit, N., & Beresford, T. P. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.002 · Cited by 25
Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
Simei, J. L. Q., Souza, J. D. R., Pedrazzi, J. F. C., Guimarães, F. S., Campos, A. C., Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. S. (2024) · Pharmaceuticals · doi:10.3390/ph17121644 · Cited by 27
Nav1.8, an analgesic target for nonpsychotomimetic phytocannabinoids
Ghovanloo, M., Tyagi, S., Zhao, P., & Waxman, S. G. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2416886122 · Cited by 23
Intrinsic Frontolimbic Connectivity and Mood Symptoms in Young Adult Cannabis Users
Shollenbarger, S. G., Thomas, A. M., Wade, N. E., Gruber, S. A., Tapert, S. F., Filbey, F. M., & Lisdahl, K. M. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00311 · Cited by 24
Global Trends in Cannabis and Cannabidiol Research from the Year 1940 to 2019
Liu, J., Chen, H., Newmaster, S. G., Wang, S., & Liu, C. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200601152118 · Cited by 22
Organic Thin‐Film Transistors as Cannabinoid Sensors: Effect of Analytes on Phthalocyanine Film Crystallization
Comeau, Z. J., Rice, N. A., Harris, C. S., Shuhendler, A. J., & Lessard, B. H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107138 · Cited by 21
Research Progress on Cannabinoids in Cannabis (Cannabis sativa L.) in China
Sun, X. (2023) · Molecules · doi:10.3390/molecules28093806 · Cited by 23
Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
Sampaio, M. D. F. D. S., de Paiva, Y. B., Sampaio, T. B., Pereira, M. G., & Coimbra, N. C. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13997 · Cited by 28
Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice
Nasehi, M., Piri, M., Abbolhasani, K., & Zarrindast, M. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283618aab · Cited by 22
Behavioral Neurobiology of the Endocannabinoid System
Kendall, D., & Alexander, S. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7 · Cited by 28
Preparation and characterization of Δ9-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines
de la Ossa, D. H. P., Gil-Alegre, M. E., Ligresti, A., Aberturas, M. R., Molpeceres, J., Torres‐Suárez, A. I., & Marzo, V. D. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.809089 · Cited by 22
Cannabinoid Signaling in Kidney Disease
Arceri, L., Nguyen, T. K., Gibson, S. G., Baker, S., & Wingert, R. A. (2023) · Cells · doi:10.3390/cells12101419 · Cited by 23
Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses
Eichler, F., Poźniak, B., Machnik, M., Schenk, I., Wingender, A., Baudisch, N., Thevis, M., Bäumer, W., Lischer, C. J., & Ehrle, A. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1234551 · Cited by 21
Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases
Paez, J. A., & Campillo, N. E. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180226095132 · Cited by 20
Cannabis use and human retina: The path for the study of brain synaptic transmission dysfunctions in cannabis users
Schwitzer, T., Schwan, R., Angioï-Duprez, K., Lalanne, L., Giersch, A., & Laprévote, V. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.001 · Cited by 20
Cannabis Sativa L. Flower and Bud Extracts Inhibited In vitro Cholinesterases and β-Secretase Enzymes Activities: Possible Mechanisms of Cannabis Use in Alzheimer Disease
Mooko, T., Bala, A., Tripathy, S., Kumar, C. S. V., Mahadevappa, C. P., Chaudhary, S. K., & Matsabisa, M. G. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666210222124349 · Cited by 21
Cellular distribution of cannabinoid‐related receptors TRPV1, PPAR‐gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia
Galiazzo, G., Silva, M. D., Giancola, F., Rinnovati, R., Peli, A., & Chiocchetti, R. (2021) · Equine Veterinary Journal · doi:10.1111/evj.13499 · Cited by 20
The Medicinal Cannabis Treatment Agreement
Wilsey, B. L., Atkinson, J. H., Marcotte, T. D., & Grant, I. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000145 · Cited by 20
Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline
Bhandari, S., & Venkatesan, T. (2016) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-016-0114-y · Cited by 20
The complexes of cannabidiol mediated by bridged cyclodextrins dimers with high solubilization, in vitro antioxidant activity and cytotoxicity
Chen, L., Yang, W., Gao, C., Liao, X., Yang, J., & Yang, B. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.117017 · Cited by 20

Authors: Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O.
Affiliations: Hebrew University of Jerusalem (IL)
Corresponding author: Mechoulam, Raphael
ORCID: Mechoulam, Raphael
Peters, Maximilian
Venue: Chemistry & Biodiversity
Publisher: Wiley
Published: 2007-08
Volume: 4
Issue: 8
Pages: 1678-1692
ISSN: 1612-1872 (ISSN-L)
1612-1880
DOI: 10.1002/cbdv.200790147
OpenAlex: W2065788111
Cited by: 515
References: 65
Citations by year: 2026: 13 · 2025: 20 · 2024: 25 · 2023: 29 · 2022: 28 · 2021: 38 · 2020: 46 · 2019: 33 · 2018: 30 · 2017: 26 · 2016: 20 · 2015: 25 · 2014: 34 · 2013: 26 · 2012: 26
FWCI: 2.19
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 20 d)
Locations: Chemistry & Biodiversity (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords: cannabidiol, cannabis, non-psychoactive cannabinoids
MeSH terms: Animals, Antioxidants, Cannabidiol, Brain Ischemia, Humans, Neoplasms, Receptors, Opioid, Neuroprotective Agents, Receptor, Serotonin, 5-HT1A, Cannabinoid Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabidiol—recent advances

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks